Imfinzi® Durvalumab is an FDA-approved immunotherapy for cancer, developed by Medimmune/AstraZeneca. The ideas and concepts were very unique for Durva, and once again I was excited to collaborate and push on the execution of the concept sketches.
Creative Direction: Dave Pasciuto
Producer: Audrey Goss and Lauren Delaney
Design: Jane Betz, Tommaso Lesnick
3d and Compositing: Colin Craig, Chris Boyd, Jack Etheridge and Dave Pasciuto
Back to Top